Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 36 Carcinoma, Non-Small-Cell Lung 17 Small Cell Lung Carcinoma 16 Neoplasms 14 Lung Neoplasms 13 Breast Neoplasms 8 Melanoma 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 6 Prostatic Neoplasms 5 Liver Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Sarcoma 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Glioblastoma 4 Endometrial Neoplasms 4 Recurrence 3 Ovarian Neoplasms 3 Neoplasms by Site 3 Neoplasms by Histologic Type 3 Carcinoma, Transitional Cell 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Small Cell Lung Cancer Extensive Stage 2 Sarcoma, Alveolar Soft Part 2 Osteosarcoma 2 Mesothelioma, Malignant 2 Mesothelioma 2

Interventions

atezolizumab 1 apatinib 1 Immune Checkpoint Inhibitors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × SCLC × atezolizumab × Clear all

NCT06179069 2026-04-03

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡